Rockefeller Capital Management L.P. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,687,064
+31.8%
70,342
+24.4%
0.01%
+25.0%
Q2 2023$2,039,037
+146277.4%
56,530
+55.0%
0.01%
+33.3%
Q1 2023$1,393
-25.5%
36,482
+10.9%
0.01%
-33.3%
Q4 2022$1,871
-99.5%
32,883
+228.4%
0.01%
+350.0%
Q3 2022$395,000
-15.4%
10,014
-5.8%
0.00%0.0%
Q2 2022$467,000
+41.1%
10,627
+27.9%
0.00%0.0%
Q1 2022$331,000
-3.5%
8,307
-2.8%
0.00%0.0%
Q4 2021$343,000
+1.5%
8,549
+2.8%
0.00%0.0%
Q3 2021$338,000
+1200.0%
8,313
+1350.8%
0.00%
Q2 2021$26,000
+18.2%
573
+7.5%
0.00%
Q1 2021$22,000
+4.8%
533
+6.6%
0.00%
Q4 2020$21,000
+61.5%
5000.0%0.00%
Q3 2020$13,000
-92.0%
500
-91.8%
0.00%
-100.0%
Q2 2020$163,000
+24.4%
6,088
-16.7%
0.00%0.0%
Q1 2020$131,000
+1355.6%
7,305
+1361.0%
0.00%
Q4 2019$9,0005000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$256,066,00016.64%
BB BIOTECH AG 8,247,860$149,864,0003.97%
MSD Partners, L.P. 2,245,000$40,792,0003.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 428,633$5,969,0002.84%
First Light Asset Management, LLC 885,523$16,090,0002.60%
SNYDER CAPITAL MANAGEMENT L P 2,387,350$43,378,0001.93%
Sterling Global Strategies LLC 22,000$400,0001.74%
Taylor Wealth Management Partners 221,380$4,022,0001.71%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,228,399$167,680,0001.68%
DOHENY ASSET MANAGEMENT /CA 124,393$2,260,0001.18%
View complete list of HALOZYME THERAPEUTICS INC shareholders